3 completed, 2 unknown, 1 not yet recruiting. 3 Phase 3, 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Unknown 1 |
| Phase 4 | 2 | Not yet recruiting 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
Follow Lansoprazole 15 mg: new trials by email Literature Review of Lansoprazole 15 mg trials Research Report on Lansoprazole 15 mg
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of Fexuprazan in Prevention of NSAIDs Induced Peptic Ulcer Fexuprazan 20mg, Lansoprazole 15 mg placebo, Lansoprazole 15 mg - NSAID (Non-Steroidal Anti-Inflammatory Drug) | Phase 4 | Not yet recruiting | Daewoong Pharmaceutical Co. LTD. | 360 | 2026-04-01 | 2026-04-16 |
| A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121 Lansoprazole 15 mg, Lansoprazole 15mg/Calcium carbonate 600mg - Gastro Esophageal Reflux | Phase 1 | Completed | Addpharma Inc. | 24 | 2023-09-15 | 2024-08-01 |
| The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole) Lansoprazole 15 mg - Coronary Artery Disease | Phase 4 | Unknown | Daejeon St. Mary's hospital | 300 | 2023-05-01 | 2023-04-19 |
| Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer DWP14012 20mg, Lansoprazole 15 mg, DWP14012 20mg placebo - Peptic Ulcer | Phase 3 | Completed | Daewoong Pharmaceutical Co. LTD. | 423 | 2021-05-21 | 2024-07-08 |
| Study to Evaluate the Safety, Efficacy of Tegoprazan for the Prevention of PUD in Patients on Treatment With NSAIDs Lansoprazole 15 mg, Tegoprazan 25 mg - Preventive Peptic Ulcer | Phase 3 | Completed | HK inno.N Corporation | 392 | 2021-05-07 | 2026-09-14 |
| Study to Evaluate the Efficacy and Safety of DWP14012 on Maintaining Healing in Subjects With Healed Erosive Esophagitis DWP14012 20 mg, DWP14012 20 mg placebo, Lansoprazole 15 mg - Healed Erosive Esophagitis | Phase 3 | Unknown | Daewoong Pharmaceutical Co. LTD. | 406 | 2020-07-02 | 2020-09-03 |
Coronary Artery Disease (1) · Gastroesophageal Reflux (1) · Peptic Ulcer (1)
Daewoong Pharmaceutical Co. LTD. (3) · Addpharma Inc. (1) · Daejeon St. Mary's hospital (1) · HK inno.N Corporation (1)
South Korea (5)
DaeWon Kim (1) · Jea Jun Kim (1)
PMID 11519503, PMID 15758000, PMID 20925534, PMID 21126648, PMID 22249527, PMID 22688850, PMID 25286881, PMID 26751904, PMID 28886622, PMID 30522654, PMID 30851041, PMID 31152740, PMID 40567214, PMID 42325011